EPCM
STJ

Eton Park Capital Management’s St Jude Medical STJ Stock Holding History

Eton Park Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,169,724
Closed -$254M – 54
2016
Q4 		$254M Buy
3,169,724
+1,702,624
+116% +$135M 5.05% 4
2016
Q3 		$117M Buy
+1,467,100
New +$118M 2.04% 14

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Eton Park Capital Management's STJ Position: Q1 2017 in Review

Eton Park Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,169,724 shares — an estimated $254M sold.

Eton Park Capital Management first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $254M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Eton Park Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Eton Park Capital Management sold 3,169,724 St Jude Medical shares in Q1 2017, an estimated $254M.
  • Eton Park Capital Management first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • Eton Park Capital Management's St Jude Medical position peaked at $254M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Eton Park Capital Management's 13F filing for Q1 2017, filed 15 May 2017.